top of page
地球横長2-.png

News

Oct 15, 2026

Read More

SiccaNova Therapeutics Completes JPY 1.4 Billion Series A Financing

Oct 14, 2026

Read More

SiccaNova Therapeutics Wins Grand Prize in the Startup Category at the NINEJP Innovation Award in BioJapan2026

Sep 3, 2026

Read More

Company Featured in Nikkei’s Online Edition

Sep 3, 2026

Read More

SiccaNova Therapeutics raises a total of 1.25 billion yen in Series A funding.

Jul 24, 2026

Read More

Asahi Pharmaceutical Co., Ltd. changes its name to "SiccaNova Therapeutics Co., Ltd."

Oct 22, 2025

Read More

Accelerating clinical trial readiness of drug candidates through investment-backed co-creation with Tohoku University

Nov 21, 2022

Read More

Patent Application for a New Therapeutic Use

Jun 24, 2022

Read More

We have successfully secured exclusive worldwide rights to develop and commercialize a compound that has completed Phase 2a.

bottom of page